Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?
- PMID: 29959268
- PMCID: PMC6024629
- DOI: 10.9745/GHSP-D-18-00206
Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?
Abstract
Newly emerging low-cost molecular assays and improved visual tests for cervical cancer screening call into question the role of visual inspection with acetic acid (VIA). VIA-based screening continues to offer a low-cost, single-visit approach for screening. However, VIA is highly rater-dependent and has problematic accuracy. RNA, DNA, and protein tests are now available. They offer greater accuracy and the option for self-sampling, but the testing kits are expensive. As these new options continue to improve, the time to move beyond VIA is fast approaching.
Figures
Comment on
-
Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.Glob Health Sci Pract. 2018 Jun 29;6(2):288-298. doi: 10.9745/GHSP-D-17-00326. Print 2018 Jun 27. Glob Health Sci Pract. 2018. PMID: 29959272 Free PMC article.
References
-
- Institute for Health Metrics and Evaluation (IHME). GBD Results Tool. Seattle, WA: IHME, University of Washington; 2016. http://ghdx.healthdata.org/gbd-results-tool. Accessed May 3, 2018.
-
- World Health Organization (WHO). Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention: WHO Guidelines. Geneva: WHO; 2013. http://www.who.int/reproductivehealth/publications/cancers/screening_and.... Accessed June 7, 2018. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous